🏛️ Verified NIH Protocol • Sourced via U.S. National Library of Medicine (Last Synced: 2026-08-24)

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

🟢 Recruiting Phase 1 💊 Investigational Drug / Biologic Sponsor: HCW Biologics

🩺 Protocol Summary

This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)

Primary Research Facility: James A. Haley Veterans' Hospital (Tampa, Florida)

📋 Basic Study Criteria & Logistics Checklist

0 of 3 Checked

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Alopecia Areata(AA)?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 18 Years and 70 Years?

🔍 Protocol Specified Age Range: 18 Years to 70 Years

Able to attend required in-person clinic visits and study procedures at one of the participating study centers?

🔍 Logistical Requirement: 3 Registered Participating Sites

📍 Primary Site Map

Site: James A. Haley Veterans' Hospital — Tampa, Florida

📍 All Participating Trial Locations (3 Sites)

Multi-Center Trial

This protocol is enrolling participants across multiple clinical centers:

1. James A. Haley Veterans' Hospital — Tampa, Florida • Contact: (813) 972-2000

2. Dawes Fretzin Clinical Research Group — Indianapolis, Indiana • Contact: (317) 516-5030

3. The Ohio State University Wexner Medical Center — Columbus, Ohio • Contact: (614) 685-0251

📄 Print Doctor Discussion Sheet

Preview and print a 1-page summary with 5 tailored questions for your physician.

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.

🏛️ Official Government Provenance

NIH ClinicalTrials.gov Protocol Record

NCT Identifier: NCT07049328 • Last Synced: 2026-08-24

View on ClinicalTrials.gov ↗